Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / EXEL - Calithera's telaglenastat shows positive action in early-stage RCC study; shares up 4%


EXEL - Calithera's telaglenastat shows positive action in early-stage RCC study; shares up 4%

  • Updated data from a Phase 1 clinical trial evaluating Calithera Biosciences' (CALA +4.1%) glutaminase inhibitor telaglenastat, combined with Exelixis' (EXEL -2.8%) Cabometyx (cabozantinib), in previously treated patients with advanced renal cell carcinoma (RCC) showed a positive effect. The results were presented at the ASCO GU Cancers Symposium in San Francisco.
  • More news on: Calithera Biosciences, Exelixis, Inc., Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Exelixis Inc.
Stock Symbol: EXEL
Market: NASDAQ
Website: exelixis.com

Menu

EXEL EXEL Quote EXEL Short EXEL News EXEL Articles EXEL Message Board
Get EXEL Alerts

News, Short Squeeze, Breakout and More Instantly...